June 2020 FDA Recall Aripiprazole by Alembic Pharmaceuticals Limited
D-1341-2020 - Labeling

This Class II drug recall was voluntarily initiated by Alembic Pharmaceuticals Limited on June 10, 2020 for the product Aripiprazole. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1341-2020

Reason for Recall
Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.
Initiated
06-10-2020
Reported
07-01-2020
Quantity
19,153 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Alembic Pharmaceuticals Limited
Nationwide in the U.S.
Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 389350, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807 USA, NDC 62332-097-30.

Batch or Lot Expiration Information

Lot# Lot: 1905003298 Exp. 01/31/2021